endometrial cancer (Cancer)

Search with Google Search with Bing
Information
Disease name
endometrial cancer
Disease ID
DOID:1380
Description
"A uterine cancer that is located_in tissues lining the uterus." [url:http\://www.cancer.gov/dictionary?CdrID=444987]
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
PMS2 7 5,970,957 6,009,122 438
MSH6 2 47,783,145 47,806,953 430
FBXO11 2 47,806,920 47,906,498 380
MSH2 2 47,403,156 47,483,223 300
EPCAM 2 47,369,311 47,387,020 98
MLH1 3 36,993,518 37,050,846 96
PTEN 10 87,863,625 87,971,930 64
KCNK12 2 47,509,290 47,570,985 64
TP53 17 7,668,421 7,687,490 6
ARID1A 1 26,696,015 26,782,104 6
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04774419 Active, not recruiting Phase 2 Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery April 2, 2021 February 2025
NCT05796518 Active, not recruiting N/A Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors September 7, 2023 June 2024
NCT00514254 Active, not recruiting Risk Factors for Endometrial Cancer in Black Women July 2007 July 2025
NCT05257057 Active, not recruiting Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome May 8, 2019 December 2024
NCT03603184 Active, not recruiting Phase 3 Atezolizumab Trial in Endometrial Cancer - AtTEnd October 2, 2018 May 2025
NCT06293066 Active, not recruiting Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study. January 31, 2024 July 15, 2024
NCT04025229 Active, not recruiting N/A High Intensity Interval Training in Endometrial Cancer May 20, 2019 September 8, 2025
NCT05216913 Active, not recruiting Optimising Cardiovascular Health in Endometrial Cancer Survivors February 9, 2022 October 2024
NCT04344795 Active, not recruiting Phase 1 Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors May 6, 2020 October 1, 2024
NCT04393285 Active, not recruiting Phase 2 Abemaciclib and Letrozole to Treat Endometrial Cancer October 10, 2020 December 1, 2025
NCT03935256 Active, not recruiting Phase 2 Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer March 5, 2019 December 31, 2024
NCT04152018 Active, not recruiting Phase 1 Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. November 13, 2019 August 30, 2024
NCT05194735 Active, not recruiting Phase 1/Phase 2 Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors April 4, 2022 November 30, 2024
NCT05169437 Active, not recruiting Phase 2 Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors March 15, 2022 January 1, 2025
NCT04577963 Active, not recruiting Phase 1/Phase 2 A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors August 9, 2021 November 2024
NCT05737745 Active, not recruiting N/A FitEx for Endometrial Cancer Survivors: Initial Efficacy February 1, 2023 June 2024
NCT00924027 Active, not recruiting Phase 2 A Study of Patients Receiving High-Dose Rate Brachytherapy April 14, 2009 July 5, 2025
NCT05717634 Active, not recruiting Endometrial Changes in Breast Cancer Women. January 26, 2023 January 26, 2024
NCT05082025 Active, not recruiting Phase 2 Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations September 27, 2022 October 29, 2026
NCT04188548 Active, not recruiting Phase 1 A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer December 10, 2019 December 2027
NCT03285230 Active, not recruiting The French E3N Prospective Cohort Study June 15, 1990 December 15, 2025
NCT05035173 Active, not recruiting N/A The LYSA (Linking You to Support and Advice) Trial March 13, 2021 April 2024
NCT00411138 Active, not recruiting Phase 3 Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer November 23, 2006 December 31, 2024
NCT00587886 Active, not recruiting Estrogen, Diet, Genetics and Endometrial Cancer September 25, 2001 December 31, 2024
NCT01068249 Active, not recruiting Phase 2 Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer April 30, 2010 April 30, 2028
NCT03555422 Active, not recruiting Phase 3 Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] January 5, 2018 December 2025
NCT02285192 Active, not recruiting Phase 1 Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer November 2014 November 2025
NCT03016338 Active, not recruiting Phase 2 Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer November 6, 2017 December 2025
NCT05538572 Active, not recruiting Phase 1 A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors December 27, 2022 December 2024
NCT04750941 Active, not recruiting Phase 2 Study of Copanlisib and Ketogenic Diet February 10, 2022 December 2024
NCT03835819 Active, not recruiting Phase 2 A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) January 2, 2020 August 1, 2028
NCT03170960 Active, not recruiting Phase 1/Phase 2 Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors September 5, 2017 August 2024
NCT04660929 Active, not recruiting Phase 1 CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors February 2, 2021 December 31, 2024
NCT04000880 Active, not recruiting N/A Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health March 4, 2020 August 31, 2024
NCT05263492 Active, not recruiting Phase 2 Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer April 1, 2022 September 30, 2025
NCT03983954 Active, not recruiting Phase 1 Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors October 10, 2019 October 1, 2026
NCT03503786 Active, not recruiting Phase 2 Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer April 1, 2018 December 2023
NCT01797523 Active, not recruiting Phase 2 A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma October 7, 2013 October 31, 2025
NCT03748186 Active, not recruiting Phase 1 Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers February 1, 2019 November 2024
NCT01226316 Active, not recruiting Phase 1 Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules December 1, 2010 December 31, 2024
NCT05931445 Active, not recruiting N/A Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer January 26, 2021 March 31, 2027
NCT01244789 Active, not recruiting Phase 2 Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer December 2011 January 15, 2025
NCT04780217 Active, not recruiting Phase 1/Phase 2 Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors August 10, 2021 August 2025
NCT04214964 Active, not recruiting Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study April 11, 2020 December 2024
NCT03285152 Active, not recruiting N/A A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients August 11, 2017 August 11, 2024
NCT00501761 Active, not recruiting Physical Activity After Endometrial Cancer May 2005 May 2025
NCT03526432 Active, not recruiting Phase 2 Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer August 8, 2018 May 2025
NCT04697264 Active, not recruiting N/A Adipocytokines in Endometrial Cancer April 12, 2021 October 2024
NCT03667716 Active, not recruiting Phase 1 COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. September 6, 2018 May 31, 2024
NCT02658565 Active, not recruiting N/A Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation January 29, 2016 November 2026
NCT03776630 Active, not recruiting N/A Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors May 23, 2019 May 2027
NCT04681248 Available Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
NCT01267461 Available Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
NCT00268918 Completed Phase 1 Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients September 2005 January 2011
NCT00287885 Completed Phase 1 Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer March 2004 December 2008
NCT00295945 Completed Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer March 2005 December 2009
NCT00315861 Completed Phase 1 Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies March 2006 January 2009
NCT00319748 Completed Phase 2 Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers April 2006 December 2008
NCT00331760 Completed Phase 2 Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery March 2006 December 2016
NCT00334321 Completed Phase 1 Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients April 2006 September 2015
NCT00339651 Completed Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer November 25, 2002 August 6, 2020
NCT00340210 Completed Extended Follow-up of Columbia, MO Serum Bank Participants January 14, 1999 September 2, 2014
NCT00340262 Completed Bone Mineral Density and Subsequent Cancer Risk April 7, 2000 March 26, 2020
NCT00340600 Completed Continuation of Follow-up of DES-Exposed Cohorts March 18, 1998 November 13, 2020
NCT00340808 Completed Molecular Staging of Endometrial Cancer March 19, 2004 July 16, 2020
NCT00342446 Completed A Follow-up Study of Women Evaluated and Treated for Infertility October 1, 1995 January 11, 2023
NCT06148129 Completed N/A Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients January 12, 2019 March 1, 2022
NCT06115577 Completed Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes October 1, 2012 August 1, 2022
NCT00376844 Completed Phase 3 External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer May 2002 April 2016
NCT00377520 Completed Phase 2 A Trial for Patients With Advanced/Recurrent Endometrial Cancer September 2006 September 2008
NCT00381888 Completed Phase 2 Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer January 2007 January 2009
NCT00388154 Completed Phase 2 Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer August 2004 November 2013
NCT00392769 Completed Phase 2 Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer October 2006 December 2010
NCT00401635 Completed Phase 2 END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin November 2002
NCT00448643 Completed Phase 1 Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery May 2002 March 2011
NCT00462969 Completed N/A Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer April 2007 September 2010
NCT06049693 Completed Phase 4 Iron Prehabilitation in Endometrial Cancer January 1, 2023 January 1, 2024
NCT00474994 Completed Phase 2 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas April 2007 November 2010
NCT00482300 Completed N/A Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer
NCT00495235 Completed Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas October 2005
NCT00505739 Completed Phase 2 Mifepristone for Patients With Endometrial Cancer and LGESS September 2001 May 2008
NCT00507741 Completed Phase 2 Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) August 2007 April 2009
NCT00508703 Completed Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy March 5, 2003 September 8, 2017
NCT00513786 Completed Phase 2 Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma August 1, 2007 January 3, 2017
NCT00515073 Completed Phase 2 Papillary Serous Carcinoma of the Endometrium April 2001 May 2013
NCT00526149 Completed Phase 2 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors July 2007
NCT00542490 Completed Phase 2 Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer September 2007 February 2016
NCT00543192 Completed Sexual Functioning in Endometrial Cancer October 2007 June 2009
NCT00545792 Completed Phase 2 Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers May 2007 October 2013
NCT00569257 Completed Phase 2 Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors December 2007 July 2011
NCT00581646 Completed Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance September 2006 June 2015
NCT00595725 Completed N/A Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma February 2003 September 2011
NCT00604994 Completed Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer June 2008 April 2013
NCT00607607 Completed Phase 2 A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer January 2008 January 2012
NCT00610740 Completed Phase 2 CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer July 2006 April 2008
NCT00612495 Completed Phase 2 Endometrial Cancer - LOHP Alone and With 5FU January 2001 March 2005
NCT00659568 Completed Phase 1 Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma March 2008 August 2010
NCT00703807 Completed Phase 1 Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers December 2008 May 2010
NCT00732173 Completed N/A Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer July 2008 March 2011
NCT00735514 Completed Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer July 2008 May 2010
NCT00739830 Completed Phase 2 Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6) August 2008 July 2012
NCT00770185 Completed Phase 2 Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer November 13, 2008 February 13, 2015
NCT00789893 Completed Study of Vaginal Dilator Use After Pelvic Radiotherapy November 2008 June 2015
NCT00842452 Completed Phase 1 Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery February 2009 April 2011
NCT00870337 Completed Phase 2 Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer March 2008
NCT00879840 Completed Assessment of Screening Modalities for Gynecologic Cancers April 9, 2009 November 16, 2020
NCT00002459 Completed Phase 3 Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus April 1988
NCT00909896 Completed Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy April 8, 2009 January 29, 2013
NCT00910091 Completed Phase 2 The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer August 2009 July 2013
NCT01013324 Completed Phase 2 Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma January 2010 March 2013
NCT01045187 Completed N/A Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer October 2008 April 2010
NCT01049126 Completed Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients July 2009 February 2010
NCT01065662 Completed Phase 1 AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies February 2010 March 2021
NCT01075386 Completed The Effects of the Endocrine System on Endometrial Cancer October 2009 December 2018
NCT05542940 Completed P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer January 1, 2020 August 31, 2022
NCT01111461 Completed Phase 2 Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression March 2010 October 2015
NCT05529303 Completed N/A Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients February 26, 2023 September 18, 2023
NCT05448586 Completed Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit? February 2, 2019 January 30, 2021
NCT01205672 Completed Early Phase 1 Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer September 16, 2010 May 28, 2017
NCT01216813 Completed Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer August 2010 December 2010
NCT01237067 Completed Phase 1 Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers February 7, 2011 December 12, 2019
NCT05378152 Completed N/A Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity September 24, 2022 February 25, 2024
NCT01256268 Completed Phase 1 Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids June 13, 2011 August 3, 2017
NCT01262040 Completed N/A Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive December 14, 2010 October 29, 2018
NCT05364905 Completed Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma May 9, 2022 November 22, 2022
NCT01364844 Completed Phase 1 Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors July 2011 November 2013
NCT01367002 Completed Phase 2 Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer June 2011 June 30, 2022
NCT01379534 Completed Phase 2 A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer November 2011 March 2014
NCT01397877 Completed Phase 2 GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer December 2011 March 2016
NCT01444456 Completed Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia October 2011
NCT05261165 Completed Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer October 1, 2015 October 1, 2021
NCT01467219 Completed N/A Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer January 2012 March 2014
NCT01470677 Completed Phase 3 Tachosil for the Prevention of Symptomatic Lymph Cysts November 2011 January 2016
NCT01482728 Completed Early Phase 1 Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer January 2012 December 2015
NCT01512810 Completed Phase 2 Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer January 2012 August 26, 2021
NCT01523678 Completed Phase 2 Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers February 2012 August 14, 2018
NCT01526655 Completed N/A Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer January 25, 2012 July 27, 2016
NCT01527396 Completed Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer December 2011 August 2015
NCT01562106 Completed N/A Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery February 2012 August 2016
NCT01580696 Completed Phase 1/Phase 2 Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer April 2012 July 31, 2016
NCT01582906 Completed A Survivorship Care Plan for Gynaecological Cancer Patients August 2011 April 2015
NCT01588522 Completed Phase 1 Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease July 2012 March 2017
NCT01610375 Completed N/A Telephone Follow-up After Treatment for Endometrial Cancer June 2012 December 2018
NCT01631552 Completed Phase 1/Phase 2 Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer December 17, 2012 August 13, 2020
NCT01672892 Completed Phase 3 Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer November 2012 May 20, 2022
NCT01673022 Completed N/A Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging May 2012 January 2017
NCT01679483 Completed N/A Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer September 2012 November 2015
NCT01679522 Completed N/A Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer January 2013 June 2022
NCT01686256 Completed Phase 1 Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer August 2001
NCT01691144 Completed Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project September 2012 December 2015
NCT04972682 Completed N/A [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer July 1, 2021 April 15, 2024
NCT01738152 Completed N/A Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health November 2012 July 21, 2021
NCT04823065 Completed Phase 1/Phase 2 4FMFES-PET Imaging of Endometrial and Ovarian Cancers September 1, 2018 April 30, 2024
NCT01761721 Completed Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics January 2013 February 2016
NCT01767155 Completed Phase 3 Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer April 2013 January 30, 2017
NCT04817501 Completed Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System February 14, 2014 December 1, 2022
NCT01793545 Completed Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples February 11, 2013 November 16, 2020
NCT01806350 Completed N/A Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors November 2009 September 2012
NCT01818739 Completed N/A Lymph Node Mapping in Patients With Endometrial Cancer March 2013 March 31, 2017
NCT01836484 Completed Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma June 2012 December 2018
NCT01851928 Completed Validation of a Nutrition Screening Tool July 2011 March 2013
NCT01886040 Completed Factors Affecting the Prognosis of Patients With Endometrial Cancer June 2013 May 2016
NCT01886066 Completed N/A Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer March 2012 September 2021
NCT01911247 Completed Early Phase 1 Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer May 2011 February 2013
NCT01914276 Completed Lymphedema in Endometrial Cancer October 2013
NCT01922778 Completed N/A Screening for Endometrial Abnormalities in Overweight and Obese Women September 2013 March 31, 2016
NCT01961102 Completed OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer May 2013 March 2016
NCT01965080 Completed Phase 2 Exemestane in Advanced and Recurrent Endometrial Carcinoma March 2004 February 2009
NCT01979003 Completed Early Phase 1 Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion September 2014 June 30, 2021
NCT00002493 Completed Phase 3 Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer May 1992
NCT02035787 Completed Phase 2 Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients February 27, 2014 April 12, 2024
NCT03900104 Completed N/A Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer May 1, 2019 January 15, 2020
NCT03629756 Completed Phase 1 A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies July 24, 2018 September 3, 2021
NCT03665285 Completed Phase 1/Phase 2 A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors October 1, 2018 April 11, 2023
NCT06394258 Completed N/A POSE - POs Surgery Endometrial Cancer June 18, 2018 October 8, 2021
NCT03694262 Completed Phase 2 The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) July 19, 2019 April 5, 2023
NCT03824613 Completed Urinary miRNA in Endometrial Cancer Study March 8, 2019 March 26, 2020
NCT03722030 Completed N/A Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors December 5, 2018 March 14, 2020
NCT03820024 Completed N/A MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback September 28, 2018 December 23, 2020
NCT00003669 Completed Phase 2 Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer November 1998 April 2001
NCT03752606 Completed Phase 4 Application of Tachosil During Lymphadenectomy November 29, 2013 December 31, 2017
NCT00003691 Completed Phase 3 Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer December 1998
NCT03813719 Completed Anxiety and Distress Levels in Women With Suspected Endometrial Cancer July 1, 2018 August 1, 2019
NCT00003749 Completed Phase 3 Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer April 1998 December 2008
NCT00003795 Completed Quality of Life in Survivors of Gynecologic Cancer April 1999
NCT00003939 Completed Phase 2 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
NCT00003946 Completed Phase 2 Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer August 1999
NCT00004082 Completed Phase 1 Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors July 1999 December 2010
NCT00004251 Completed Phase 2 Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer January 19, 2000 January 18, 2011
NCT00004915 Completed Phase 2 Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer November 1998 February 2000
NCT00005031 Completed Phase 2 Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer August 2000
NCT00005583 Completed Phase 3 Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer January 2000 July 2010
NCT00005643 Completed Phase 2 Chemotherapy in Treating Patients With Sarcoma of the Uterus May 2000
NCT00005861 Completed Phase 2 Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer May 2000
NCT00006005 Completed Phase 2 Thalidomide in Treating Patients With Gynecologic Sarcomas September 2000 August 2006
NCT00006027 Completed Phase 3 Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer August 2000
NCT00006357 Completed Phase 1/Phase 2 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma August 2000
NCT00006377 Completed Phase 2 Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer June 2000 January 2003
NCT00010829 Completed Phase 2 Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors January 2001 December 2005
NCT00019331 Completed Phase 2 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors October 1997 May 2007
NCT00022620 Completed Phase 2 Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer June 2001
NCT00023894 Completed Phase 2 Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer July 2001 February 2006
NCT00030485 Completed Phase 2 Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer January 2002 April 2007
NCT00032162 Completed Phase 1/Phase 2 Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer August 2001
NCT00033358 Completed Phase 2 Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer February 2002
NCT00033605 Completed Phase 3 Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis April 2002 July 2006
NCT00052312 Completed Phase 2 Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer September 2002
NCT00053794 Completed Phase 2 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma June 9, 2003 September 22, 2008
NCT00071929 Completed Phase 2 Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer November 1999 September 2007
NCT00085332 Completed Phase 2 Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) July 2004
NCT00087100 Completed Phase 2 Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer May 2006
NCT00087685 Completed Phase 2 RAD001 in Recurrent Endometrial Cancer Patients June 2004 January 2015
NCT00096408 Completed Phase 3 Laparoscopic Approach to Cancer of the Endometrium October 2005 December 2018
NCT00099008 Completed Phase 1 Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women March 2004 July 2006
NCT00122343 Completed Phase 2 AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) August 2005 January 2008
NCT00171808 Completed Phase 2 Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer April 2005
NCT00190697 Completed Phase 4 A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment January 2001 April 2007
NCT00205023 Completed N/A Disseminated Endometrial Cancer Cells During Sonohysterography January 2004 August 2006
NCT00245050 Completed Phase 3 Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer April 2004 September 2011
NCT00247923 Completed N/A Endometrial Polyps: Pathophysiology and Clinical Consequences October 2005 February 2009
NCT00249990 Completed Phase 2 Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) April 2003 September 2007
NCT00258362 Completed Phase 2 Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer July 2005 December 2009
NCT00262938 Completed N/A Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission February 2005 August 2011
NCT00267488 Completed Phase 2 Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer October 2005 December 2007
NCT03169023 Completed N/A Scale Down for Endometrial Cancer February 21, 2017 February 3, 2019
NCT03171506 Completed N/A Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification November 9, 2015 July 18, 2017
NCT03189446 Completed Phase 2 Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer October 2, 2017 October 6, 2021
NCT03192059 Completed Phase 2 Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer July 1, 2017 June 30, 2021
NCT03207074 Completed N/A Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? June 13, 2017 June 1, 2020
NCT04120649 Completed Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma May 18, 2020 August 1, 2022
NCT03210129 Completed N/A Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients July 6, 2017 February 28, 2019
NCT03314935 Completed Phase 1/Phase 2 A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors November 21, 2017 November 28, 2022
NCT04068675 Completed N/A Effects of Centering Pre-operative Counseling on Patient Reported Anxiety February 24, 2020 June 30, 2021
NCT03330015 Completed Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding June 3, 2016 September 26, 2017
NCT03339843 Completed Phase 2 Multiorgan Metabolic Imaging Response Assessment of Abemaciclib December 19, 2018 December 20, 2023
NCT03345485 Completed Phase 1/Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors October 6, 2017 March 29, 2023
NCT04021459 Completed N/A Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery. September 16, 2019 September 16, 2021
NCT00003127 Completed Phase 2 S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer February 1998 July 2004
NCT03366480 Completed Phase 1/Phase 2 A Study to Assess the Efficacy and Safety of ABTL0812 December 1, 2016 November 15, 2020
NCT03394027 Completed Phase 2 ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma January 17, 2018 October 7, 2021
NCT03395080 Completed Phase 2 A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma March 5, 2018 January 27, 2021
NCT03454451 Completed Phase 1 CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers April 25, 2018 February 19, 2023
NCT03456791 Completed Human Epididymis Protein 4 in Endometrial Carcinoma December 1, 2017 July 30, 2018
NCT03466788 Completed N/A Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer March 29, 2018 March 28, 2019
NCT03476798 Completed Phase 2 Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium June 29, 2018 September 29, 2023
NCT03962140 Completed CT Assessment of BMI in Endometrial Cancer Patients August 1, 2019 March 31, 2021
NCT03514121 Completed Early Phase 1 FPA150 in Patients With Advanced Solid Tumors March 27, 2018 May 10, 2021
NCT00003267 Completed Phase 3 Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer February 1998
NCT00003334 Completed Phase 2 Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract March 1997
NCT03926936 Completed Phase 2 FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study March 13, 2019 December 27, 2022
NCT03908996 Completed N/A the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer February 11, 2019 January 11, 2021
NCT03898947 Completed Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies January 2007 December 2019
NCT02058550 Completed Phase 1 Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy September 2014 October 23, 2020
NCT02068820 Completed N/A Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG September 2012 January 2015
NCT02069158 Completed Phase 1 Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor April 2014 May 2019
NCT02091050 Completed Phase 2 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy June 2014 January 2017
NCT02096783 Completed N/A Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer September 2014 June 2016
NCT04705649 Completed N/A Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer July 14, 2020 June 22, 2023
NCT02131558 Completed N/A Indocyanine Green and Near-infrared Fluorescence Imaging to Detect Sentinel Lymph Nodes in Patients With Endometrial Cancer May 2014 March 8, 2017
NCT02135562 Completed N/A Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors August 8, 2014 April 19, 2017
NCT02178722 Completed Phase 1/Phase 2 Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers July 17, 2014 November 6, 2020
NCT02209532 Completed N/A A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping December 2015 June 2017
NCT02226302 Completed Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer July 2014 August 2021
NCT02262455 Completed Phase 1 Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors October 2014 January 13, 2017
NCT02269293 Completed Phase 1 Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers October 13, 2014 April 20, 2021
NCT00002641 Completed Phase 3 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma February 1995 June 2012
NCT02320565 Completed N/A 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial October 2014 March 2015
NCT02335775 Completed Lymph Node Counts in Endometrial Cancer Staging July 2008 September 2015
NCT02351479 Completed N/A Hula, a Physical Activity Intervention for Female-Cancer Survivors September 2013 December 2017
NCT04626895 Completed N/A Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers June 4, 2019 October 1, 2020
NCT02413606 Completed N/A ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More? September 2015 March 2022
NCT02431676 Completed Phase 2 Survivorship Promotion In Reducing IGF-1 Trial May 2015 December 2018
NCT04560491 Completed Intraoperative Examination of Sentinel Node in Endometrial Cancer (TRSGO-SLN-003) February 1, 2016 June 30, 2020
NCT02466061 Completed N/A TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors July 2014 June 2016
NCT04534309 Completed N/A Behavioral Weight Loss Program for Cancer Survivors in Maryland September 22, 2020 June 30, 2023
NCT00002764 Completed Phase 3 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma April 1996
NCT02549209 Completed Phase 2 Pembro/Carbo/Taxol in Endometrial Cancer August 22, 2017 February 10, 2022
NCT02549989 Completed Phase 2 Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer September 2015 March 23, 2022
NCT04513665 Completed Phase 2 ZW25 in Women With Endometrial Cancers August 12, 2020 March 8, 2024
NCT04456972 Completed N/A Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. June 19, 2020 January 8, 2022
NCT04334239 Completed Effectiveness of Care in Certified Cancer Centres in Germany May 1, 2017 August 31, 2021
NCT02622776 Completed N/A Advanced Methods for Cancer Detection by Vaginal Screening February 2016 December 2018
NCT00002807 Completed N/A Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery July 4, 1996 December 21, 2009
NCT02630823 Completed Phase 1 MK-3475 Immunotherapy in Endometrial Carcinoma February 5, 2016 October 3, 2020
NCT00002920 Completed Phase 3 S9630, Medroxyprogesterone in Treating Women With Breast Cancer March 1997 December 2009
NCT04318340 Completed N/A A Novel Tapered Applicator for Vaginal Vault Brachytherapy July 16, 2020 March 20, 2023
NCT02646748 Completed Phase 1 Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors January 25, 2016 November 20, 2020
NCT04302714 Completed N/A Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer March 20, 2017 February 25, 2020
NCT04298827 Completed N/A Gyn Onc Prehab Study July 21, 2020 March 1, 2024
NCT04281043 Completed Quality of Life After Robotic Surgery for Endometrial Cancer June 15, 2019 September 15, 2021
NCT02690766 Completed N/A Translating Healthy Lifestyle Interventions for Cancer Survivors March 2015 May 2016
NCT02714621 Completed N/A MR-HIFU for Recurrent Gynaecological Cancer May 2016 March 31, 2020
NCT02725489 Completed Phase 2 Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers June 3, 2016 December 2, 2020
NCT02730416 Completed Phase 2 Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer December 12, 2016 November 25, 2021
NCT02730429 Completed Phase 2 Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer February 15, 2017 December 15, 2021
NCT02744898 Completed Phase 2 A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus July 2016 March 1, 2020
NCT04246580 Completed Evaluation of Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in Endometrial and Cervical Cancer January 2014 November 2022
NCT04240730 Completed Transvaginal Natural Orifice Endoscopic Surgery for Extremely Obese Patients With Early-stage Endometrial Cancer January 1, 2019 June 30, 2019
NCT02767362 Completed Early Phase 1 A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium November 2015 September 26, 2019
NCT02774395 Completed Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine May 2016 May 2018
NCT02826291 Completed SLNM in Endometrial Cancer Combined With OSNA March 2016 February 1, 2018
NCT02834988 Completed Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer July 28, 2016 February 10, 2020
NCT04237090 Completed Phase 3 Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel February 14, 2020 September 4, 2020
NCT02912767 Completed Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer July 20, 2016 June 1, 2020
NCT02914470 Completed Phase 1 Carboplatin-cyclophosphamide Combined With Atezolizumab January 2017 October 2021
NCT00002949 Completed Phase 1 Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis July 1996 May 2001
NCT02943811 Completed Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer October 2016 October 2016
NCT02987777 Completed Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer January 2016 August 2016
NCT02988817 Completed Phase 1/Phase 2 Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors November 23, 2016 November 12, 2021
NCT03015129 Completed Phase 2 A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer January 2017 December 30, 2022
NCT04212377 Completed Phase 2 Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients April 8, 2019 March 9, 2021
NCT04205630 Completed Phase 2 SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma May 28, 2020 April 25, 2023
NCT04956601 Not yet recruiting N/A Adjuvant Radiotherapy in Patients With Early Endometrial Cancer July 2021 August 2029
NCT05974995 Not yet recruiting N/A Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer September 1, 2023 September 1, 2029
NCT06366347 Not yet recruiting Phase 2 ALPINE: Maintenance Letrozole/Abemaciclib vs Pembrolizumab September 2024 March 1, 2029
NCT06360653 Not yet recruiting N/A a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer June 2024 June 2026
NCT05998798 Not yet recruiting Revealing Engagement Patterns Among Endometrial Cancer Patients September 2024 September 2026
NCT06284343 Not yet recruiting Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study April 1, 2024 September 30, 2026
NCT06066216 Not yet recruiting Phase 2 Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer February 1, 2024 October 31, 2026
NCT05289648 Not yet recruiting Early Phase 1 Niraparib in High-grade Endometrial Cancer Trial May 1, 2024 January 31, 2026
NCT05783986 Not yet recruiting Developing a MRI-based Deep Learning Model to Predict MMR Status April 17, 2023 December 31, 2024
NCT05793333 Not yet recruiting Predictors of Node Positivity in Endometrial Cancer August 10, 2023 December 31, 2023
NCT05489848 Not yet recruiting Phase 2/Phase 3 Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation August 20, 2022 August 20, 2030
NCT06440018 Not yet recruiting INSPIRE: A Multi-Cancer Early Detection Study June 20, 2024 February 28, 2025
NCT05524389 Not yet recruiting Phase 3 Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions December 1, 2022 June 30, 2027
NCT06385548 Not yet recruiting Phase 1/Phase 2 Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer May 2024 April 2026
NCT06463028 Not yet recruiting Phase 2 Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel, Serabelisib With Paclitaxel, and Paclitaxel Alone in Patients With Advanced/Recurrent Endometrial Cancer September 30, 2024 September 2029
NCT06073184 Not yet recruiting Phase 2 Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium September 2024 September 2031
NCT06297811 Not yet recruiting Phase 2 Myeloprotection With Trilaciclib in Pan-cancer Population March 1, 2024 December 31, 2027
NCT05550558 Not yet recruiting Phase 2 Camrelizumab Plus Anlotinib in Patients With Recurrent Sporadic MMRd Endometrial Cancer November 1, 2022 November 30, 2027
NCT06409052 Not yet recruiting Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women August 30, 2024 August 3, 2026
NCT06340568 Not yet recruiting Phase 3 A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer August 2024 December 2028
NCT05805358 Not yet recruiting Phase 2 Hyperpolarized 13C MRI for Cancer Immunotherapy November 1, 2023 July 31, 2026
NCT06457997 Not yet recruiting Phase 1 A Study of PHN-010 in Patients With Advanced Solid Tumors July 2024 July 2027
NCT03238053 Not yet recruiting N/A Laser Treatment of Genito-urinary Syndrome in Women October 1, 2022 December 31, 2026
NCT05755893 Not yet recruiting Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53 April 1, 2023 August 1, 2025
NCT06238284 Not yet recruiting HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China January 26, 2024 May 31, 2024
NCT04227249 Not yet recruiting 3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer April 2020 March 2027
NCT05824481 Not yet recruiting Phase 2 Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer June 1, 2023 June 30, 2026
NCT06268626 Not yet recruiting Detection of Endometrial Cancer Through Risk Modelling April 2024 January 2027
NCT05795244 Recruiting Phase 2 Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC) October 31, 2023 December 2029
NCT00005095 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention March 2000 December 2040
NCT02012699 Recruiting Integrated Cancer Repository for Cancer Research November 1, 2013 December 2099
NCT02288676 Recruiting DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics January 2014 October 2026
NCT02543710 Recruiting Phase 4 Biomarker Guided Treatment in Gynaecological Cancer October 2015 December 2033
NCT02628067 Recruiting Phase 2 Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) December 18, 2015 May 4, 2027
NCT02632448 Recruiting Phase 1/Phase 2 A Study of LY2880070 in Participants With Advanced or Metastatic Cancer May 16, 2016 September 30, 2025
NCT02922764 Recruiting Phase 1 A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer November 2016 May 2024
NCT03212404 Recruiting Phase 1 Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers September 20, 2017 December 2024
NCT03366051 Recruiting N/A Sentinel Node Mapping in High Risk Endometrial Cancer December 22, 2017 December 20, 2024
NCT03452774 Recruiting SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry January 1, 2018 June 2027
NCT03463252 Recruiting Phase 2/Phase 3 Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC April 1, 2018 December 30, 2030
NCT03538665 Recruiting The DETECT Study: Discovery and Evaluation of Testing for Endometrial Cancer in Tampons July 1, 2019 August 11, 2025
NCT03543215 Recruiting Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? July 13, 2017 December 10, 2025
NCT03675893 Recruiting Phase 2 RESOLVE: Abemaciclib + Letrozole +/- Metformin or Zotatifin in Endometrial or Low-Grade Serous Ovarian Cancer December 24, 2018 August 1, 2029
NCT03682289 Recruiting Phase 2 Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors January 17, 2019 July 31, 2025
NCT03746431 Recruiting Phase 1/Phase 2 A Phase 1/2 Study of [225Ac]-FPI-1434 Injection January 17, 2019 June 2026
NCT03785288 Recruiting Phase 3 Vaginal Cuff Brachytherapy Fractionation Study January 17, 2019 January 1, 2026
NCT03787056 Recruiting N/A Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients December 4, 2018 January 4, 2028
NCT04463771 Recruiting Phase 2 Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. January 26, 2021 May 31, 2026
NCT04486352 Recruiting Phase 1/Phase 2 A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer October 20, 2021 October 2026
NCT04492995 Recruiting Phase 2 Sentinel Node in Endometrial Cancer October 5, 2020 September 30, 2023
NCT04504006 Recruiting European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III October 10, 2017 January 1, 2030
NCT04512144 Recruiting N/A Mindfulness in Endometrial and Cervical Cancer July 25, 2020 July 30, 2024
NCT04514692 Recruiting Phase 1/Phase 2 Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging February 1, 2021 May 1, 2026
NCT04527900 Recruiting Phase 2 The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach February 23, 2021 September 1, 2028
NCT04569773 Recruiting Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer September 23, 2020 September 23, 2024
NCT04570553 Recruiting N/A Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers October 15, 2020 June 30, 2024
NCT04577950 Recruiting N/A A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer January 21, 2021 December 2024
NCT04585750 Recruiting Phase 1/Phase 2 The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) October 29, 2020 July 14, 2026
NCT04586959 Recruiting N/A Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer May 21, 2021 October 2025
NCT04590326 Recruiting Phase 1/Phase 2 A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018 December 9, 2020 April 27, 2027
NCT04631731 Recruiting Phase 1/Phase 2 Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity December 15, 2020 December 10, 2025
NCT04644068 Recruiting Phase 1/Phase 2 Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies November 12, 2020 December 15, 2026
NCT04683653 Recruiting N/A Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer January 15, 2021 May 22, 2025
NCT04706962 Recruiting Phase 1 TH1902 in Patients With Advanced Solid Tumors March 4, 2021 December 2024
NCT04763915 Recruiting N/A Improving Care After Inherited Cancer Testing August 5, 2022 December 2028
NCT04783467 Recruiting N/A Time Restricted Eating (TRE) Among Endometrial Cancer Patients October 7, 2021 June 2024
NCT04789694 Recruiting Phase 3 Prehabilitation in Gynaecological Cancer Patients January 25, 2021 June 30, 2026
NCT04845425 Recruiting Analysis of miRNA Expression in Endometrial Cancer April 1, 2021 December 2022
NCT04845828 Recruiting N/A Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer January 26, 2022 December 1, 2029
NCT04925284 Recruiting Phase 1 Study of XB002 in Subjects With Solid Tumors (JEWEL-101) June 7, 2021 October 7, 2024
NCT04930159 Recruiting N/A Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence September 1, 2021 September 30, 2025
NCT04945187 Recruiting N/A Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study) May 17, 2021 February 1, 2024
NCT04995731 Recruiting Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer September 1, 2021 July 2024
NCT04997096 Recruiting N/A Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy April 2, 2022 April 30, 2025
NCT05001282 Recruiting Phase 1/Phase 2 A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) September 13, 2021 June 15, 2025
NCT05026073 Recruiting Vibrational Spectroscopy for Endometrial Cancer Diagnosis January 19, 2020 November 2024
NCT05032040 Recruiting Phase 2 A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies July 21, 2022 May 30, 2025
NCT05034991 Recruiting The Role of Endometrial Blood Flow in Endometrial Cancer January 5, 2021 December 31, 2029
NCT05051722 Recruiting Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer August 3, 2021 December 30, 2025
NCT05056077 Recruiting N/A Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) October 21, 2021 December 31, 2027
NCT05057013 Recruiting Phase 1/Phase 2 HMBD-001 in Advanced HER3 Positive Solid Tumours November 10, 2021 September 2026
NCT05099978 Recruiting Asian Multicenter Prospective Study of ctDNA Sequencing November 1, 2021 December 31, 2024
NCT05103683 Recruiting Phase 1 First in Human Study of TORL-1-23 in Participants With Advanced Cancer November 17, 2021 November 15, 2025
NCT05123482 Recruiting Phase 1/Phase 2 A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies October 18, 2021 December 30, 2025
NCT05129969 Recruiting Registry Platform Ovarian and Endometrial Cancer November 25, 2021 December 2027
NCT05142033 Recruiting Avera Cancer Sequencing and Analytics Protocol (ASAP) November 1, 2021 December 31, 2026
NCT05143970 Recruiting Phase 1 A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors January 21, 2022 February 2026
NCT05162846 Recruiting N/A Methods for Increasing Genetic Testing Uptake in Michigan April 21, 2022 December 31, 2026
NCT05201547 Recruiting Phase 3 Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line April 15, 2022 October 2029
NCT05220033 Recruiting N/A Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer July 14, 2020 December 1, 2025
NCT05242276 Recruiting Uterine Manipulator in Endometrial Cancer Surgery: Pro MUCEI Study March 20, 2022 March 20, 2026
NCT05252416 Recruiting Phase 1/Phase 2 (VELA) Study of BLU-222 in Advanced Solid Tumors April 7, 2022 September 30, 2026
NCT05255653 Recruiting Phase 2/Phase 3 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features November 11, 2021 January 1, 2031
NCT05287048 Recruiting Evaluation of MCM5 in Postmenopausal Bleeding Patients March 1, 2022 September 2023
NCT05320757 Recruiting Early Phase 1 Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients April 1, 2022 March 31, 2025
NCT05366881 Recruiting cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease May 3, 2022 December 2026
NCT05377996 Recruiting Phase 1 A Study of XMT-1660 in Participants With Solid Tumors August 15, 2022 May 2027
NCT05383482 Recruiting Phase 1/Phase 2 Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 June 30, 2022 December 31, 2025
NCT05396794 Recruiting Bariatric Education for Women With Obesity and Endometrial Cancer August 30, 2023 August 2025
NCT05446324 Recruiting Phase 3 Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer February 15, 2023 September 1, 2024
NCT05454358 Recruiting Phase 2/Phase 3 Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP August 2, 2022 July 9, 2030
NCT05483023 Recruiting Phase 2 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy February 15, 2024 December 2026
NCT05489211 Recruiting Phase 2 Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) September 6, 2022 August 19, 2026
NCT05498597 Recruiting Phase 1 AMT-151 in Patients With Selected Advanced Solid Tumours January 25, 2023 October 30, 2024
NCT05500508 Recruiting Phase 1/Phase 2 Oral AMXT 1501 Dicaprate in Combination With IV DFMO November 29, 2022 September 30, 2024
NCT05504161 Recruiting Detection of Tumor DNA Through Cervical Smear and Liquid Biopsy in Endometrial Cancer Patients and Evaluation of Prognostic and Predictive Values of Tumor DNA Assay December 30, 2020 December 2023
NCT05520099 Recruiting Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform June 26, 2023 January 2027
NCT05527184 Recruiting Phase 1 First in Human Study of IMGN151 in Recurrent Endometrial Cancer and Recurrent, High-grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers January 11, 2023 December 30, 2025
NCT05542407 Recruiting Phase 1 ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer August 16, 2023 January 15, 2025
NCT05559879 Recruiting Phase 1/Phase 2 Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma August 20, 2023 December 2025
NCT05572684 Recruiting Phase 1/Phase 2 A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors October 6, 2022 November 2025
NCT05579366 Recruiting Phase 1/Phase 2 PRO1184 for Advanced Solid Tumors December 7, 2022 April 2026
NCT05591131 Recruiting N/A Genetic Testing in African Americans April 20, 2023 November 2027
NCT05610501 Recruiting Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. May 1, 2021 April 30, 2024
NCT05611931 Recruiting Phase 3 Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma April 18, 2023 January 31, 2028
NCT05634499 Recruiting Phase 2 A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer June 27, 2023 December 31, 2025
NCT05635123 Recruiting A Cohort Study of Uterine Malignancies September 15, 2023 December 1, 2030
NCT05640999 Recruiting Phase 2 Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER December 19, 2022 June 30, 2029
NCT05655598 Recruiting Phase 1 TAS-116 Plus Palbociclib in Breast and Rb-null Cancer September 12, 2023 August 2025
NCT05677048 Recruiting N/A Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention April 14, 2023 October 31, 2027
NCT05683418 Recruiting Phase 1 A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors February 15, 2023 December 2025
NCT05691010 Recruiting Early Phase 1 A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer January 10, 2023 January 10, 2025
NCT05697601 Recruiting Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools February 28, 2023 June 30, 2024
NCT05707312 Recruiting Staging Endometrial caNcer Based on molEcular ClAssification January 1, 2023 December 31, 2023
NCT05728814 Recruiting DOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer March 7, 2023 September 12, 2024
NCT05737797 Recruiting N/A Non-Invasive Diagnosis of Endometrial Cancer March 3, 2023 October 10, 2024
NCT05738902 Recruiting Adherence and Compliance to ERAS in Gynecological Surgery May 30, 2023 March 31, 2025
NCT05743517 Recruiting N/A Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) September 15, 2023 August 1, 2029
NCT05761951 Recruiting Phase 2 Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer August 29, 2023 January 31, 2029
NCT05797831 Recruiting Phase 2/Phase 3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer July 17, 2023 July 2027
NCT05807672 Recruiting Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer April 23, 2022 December 31, 2025
NCT05812677 Recruiting Early Phase 1 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer February 6, 2023 February 6, 2026
NCT05819892 Recruiting Phase 1 Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer July 17, 2023 March 1, 2028
NCT05827614 Recruiting Phase 1 Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications March 24, 2023 September 30, 2027
NCT05855941 Recruiting Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN) May 23, 2023 May 2032
NCT05857631 Recruiting N/A Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study May 29, 2023 May 25, 2029
NCT05858736 Recruiting Phase 1 Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors July 11, 2023 June 15, 2025
NCT05876130 Recruiting N/A Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer November 1, 2022 December 31, 2031
NCT05887492 Recruiting Phase 1/Phase 2 Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors June 12, 2023 June 2025
NCT05912972 Recruiting Development and Management of Registry in Patients With Gynecologic Cancer in Korea October 21, 2022 October 21, 2027
NCT05914974 Recruiting Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies September 11, 2023 April 2035
NCT05955079 Recruiting Circulating Tumor DNA Study in Patients With Endometrial Cancer January 1, 2021 January 2026
NCT05955105 Recruiting Phase 1/Phase 2 A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies July 25, 2023 July 24, 2026
NCT05969405 Recruiting Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy July 7, 2023 December 31, 2024
NCT05979610 Recruiting Phase 2 Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies October 9, 2023 April 1, 2027
NCT05990426 Recruiting N/A Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy October 16, 2023 August 2026
NCT05997017 Recruiting Phase 2 Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer December 28, 2023 October 2026
NCT06014190 Recruiting Phase 2 HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer December 18, 2023 December 31, 2027
NCT06014580 Recruiting Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil November 27, 2023 September 30, 2025
NCT06024109 Recruiting Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy March 19, 2024 January 2026
NCT06028724 Recruiting A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) May 26, 2023 May 31, 2030
NCT06036836 Recruiting Phase 2 Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) September 29, 2023 March 9, 2027
NCT06038032 Recruiting N/A ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial March 25, 2024 March 2028
NCT06083779 Recruiting Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics August 1, 2023 April 30, 2024
NCT06096688 Recruiting Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction May 29, 2019 December 31, 2026
NCT06132958 Recruiting Phase 3 Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) December 6, 2023 January 10, 2028
NCT06136884 Recruiting Phase 1 A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors November 2, 2023 January 27, 2027
NCT06163963 Recruiting N/A Sentinel Lymph Node in Early-Stage Endometrium Cancer July 1, 2023 May 2026
NCT06171789 Recruiting Phase 1/Phase 2 PRO1107 in Patients With Advanced Solid Tumors January 29, 2024 February 2027
NCT06172478 Recruiting Phase 2 A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors February 26, 2024 April 30, 2026
NCT06180733 Recruiting Phase 2 Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer December 1, 2023 January 2028
NCT06184867 Recruiting Early Phase 1 Choices About Genetic Testing And Learning Your Risk With Smart Technology October 26, 2023 January 31, 2025
NCT06206083 Recruiting Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis March 1, 2024 February 1, 2027
NCT06218914 Recruiting Phase 1 A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation February 5, 2024 January 2, 2040
NCT06239194 Recruiting Phase 1/Phase 2 Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors June 12, 2024 February 2029
NCT06242470 Recruiting Phase 1 A Study of MGC026 in Participants With Advanced Solid Tumors March 6, 2024 October 2028
NCT06250010 Recruiting Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence December 13, 2022 December 13, 2025
NCT06257264 Recruiting Phase 1 A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors February 28, 2024 December 31, 2026
NCT06264921 Recruiting Phase 1 A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors February 23, 2024 May 2025
NCT06273878 Recruiting From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy January 15, 2023 January 15, 2025
NCT06276491 Recruiting Phase 1 Phase 1, Safety and Tolerability Study of XmAb®541 in Advanced Solid Tumors April 4, 2024 December 2028
NCT06279832 Recruiting N/A Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer. November 1, 2023 October 31, 2025
NCT06293898 Recruiting Phase 1 Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors February 9, 2024 August 24, 2027
NCT06294886 Recruiting Vaginal Fluid Collection for Detection of Endometrial Cancer February 19, 2024 June 1, 2024
NCT06299163 Recruiting Phase 1 NM32-2668 in Adult Patients With Selected Advanced Solid Tumors May 1, 2024 December 31, 2027
NCT06307886 Recruiting Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator September 1, 2023 September 1, 2028
NCT06321068 Recruiting Phase 2/Phase 3 BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer April 9, 2024 October 2027
NCT06339827 Recruiting N/A ASk Questions in GYnecologic Oncology (ASQ-GYO) April 4, 2024 May 2027
NCT06341855 Recruiting N/A Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer January 25, 2024 January 30, 2026
NCT06354738 Recruiting N/A Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment January 16, 2023 November 1, 2028
NCT06395519 Recruiting Phase 1 A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies May 2024 December 2026
NCT06432478 Recruiting N/A 3D Printed Custom Applicators for HDR BT (DISCO) November 24, 2023 September 2028
NCT06447064 Recruiting Cancer Loyalty Card Study 2 (CLOCS-2) April 29, 2024 March 31, 2027
NCT03832361 Recruiting Phase 2 Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer July 15, 2020 October 2028
NCT03860272 Recruiting Phase 1 Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer April 1, 2019 December 2026
NCT03876860 Recruiting N/A An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis September 24, 2018 April 1, 2024
NCT03924466 Recruiting Phase 2 Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients April 1, 2019 December 2024
NCT03931265 Recruiting Ketohexokinase Isoforms in Endometrial Cancer. April 11, 2019 December 31, 2024
NCT03932409 Recruiting Phase 1 Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer February 19, 2020 September 2025
NCT03955978 Recruiting Phase 1 TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer October 15, 2019 July 31, 2026
NCT04008563 Recruiting N/A Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium April 1, 2021 July 31, 2025
NCT04044859 Recruiting Phase 1 ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) August 20, 2019 April 30, 2037
NCT04080284 Recruiting Phase 2 Trial of Maintenance With Niraparib- Uterine Serous Carcinoma December 30, 2019 July 1, 2026
NCT04104776 Recruiting Phase 1/Phase 2 A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas September 18, 2019 March 1, 2026
NCT04122235 Recruiting N/A The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study November 18, 2019 December 31, 2030
NCT04149691 Recruiting Phase 1 Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies July 19, 2019 June 2024
NCT04196257 Recruiting Phase 1 BP1001-A in Patients With Advanced or Recurrent Solid Tumors August 19, 2022 October 2024
NCT04235179 Recruiting Phase 2 Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer January 16, 2020 January 2026
NCT04290299 Recruiting Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive September 15, 2015 April 8, 2025
NCT04291612 Recruiting Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease February 26, 2020 February 26, 2025
NCT04362046 Recruiting N/A Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia November 15, 2020 July 2028
NCT04386993 Recruiting Phase 1 De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer July 7, 2020 August 31, 2025
NCT04403867 Recruiting The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. January 2, 2020 January 2027
NCT04453904 Recruiting N/A Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer May 12, 2020 April 2027
NCT04458402 Recruiting N/A Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer February 4, 2021 July 4, 2025
NCT05124743 Suspended HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors September 24, 2021 May 28, 2028
NCT06253494 Suspended Phase 1/Phase 2 Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer May 14, 2024 December 31, 2028
NCT05506800 Suspended Guangzhou Women's Health Cohort Study (GWHCS) March 3, 2016 August 21, 2026
NCT00161226 Terminated A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35 February 2004 June 2006
NCT00375804 Terminated Racial Disparity in Endometrial Cancer June 2003 June 2010
NCT05332483 Terminated Phase 1 Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer July 5, 2022 October 12, 2023
NCT03324958 Terminated N/A VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients. March 26, 2019 March 4, 2021
NCT04511026 Terminated Phase 2 Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer January 20, 2021 June 10, 2021
NCT00566644 Terminated Phase 3 Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome July 2007 August 2009
NCT02558348 Terminated Phase 1/Phase 2 Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) November 2015 May 30, 2017
NCT02907073 Terminated Phase 1/Phase 2 Positron Emission Tomography (PET) Imaging Studies With NIS Reporter September 2016 December 2017
NCT00471120 Terminated N/A Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer November 2006 February 2008
NCT02765698 Terminated Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer May 2016 March 2018
NCT01251354 Terminated Phase 2 Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy November 2010 July 2011
NCT05107739 Terminated Phase 1 A Study of DeTIL-0255 in Adults With Advanced Malignancies December 22, 2021 May 9, 2023
NCT02476955 Terminated Phase 1 Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole June 9, 2015 May 7, 2019
NCT00669422 Terminated ChemoFx® PRO - A Post-Market Data Collection Study October 2006 October 2012
NCT00003179 Terminated Phase 2 Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer November 1998
NCT00002976 Terminated Phase 3 Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer June 1997
NCT02393248 Terminated Phase 1/Phase 2 Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) February 27, 2015 December 17, 2021
NCT03694834 Terminated Early Phase 1 Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer March 29, 2019 October 23, 2023
NCT04586335 Terminated Phase 1 Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. September 28, 2020 February 15, 2023
NCT00394602 Terminated Chemoradiation-Induced Nausea and Emesis: Quality of Life April 7, 2004 May 8, 2019
NCT02665962 Terminated N/A Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer July 2015 July 2018
NCT00671606 Terminated Phase 2 Hysteroscopic Lymphatic Mapping for Endometrial Cancer April 2008 June 2010
NCT03572478 Terminated Phase 1/Phase 2 Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer August 14, 2018 October 1, 2020
NCT02589366 Terminated Phase 1 Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium November 2015 April 2018
NCT00900562 Terminated Phase 2 Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy August 2009 September 2011
NCT00883116 Terminated Phase 3 A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer August 2009 February 2014
NCT03466034 Terminated The Role of Hypoxia as a Selective Pressure for TP53 Mutations February 6, 2018 July 30, 2019
NCT05877404 Terminated Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer August 15, 2023 February 28, 2024
NCT01401829 Terminated Phase 1 Psychosocial Benefits of Exercise in Endometrial Cancer Survivors July 2011 January 2013
NCT02566811 Terminated N/A Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC) April 12, 2017 August 14, 2019
NCT01641497 Terminated N/A Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer May 2012 October 2016
NCT00016341 Terminated Phase 3 Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer May 2001
NCT00470067 Terminated Phase 2 Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer February 2007 December 2009
NCT00003624 Terminated Phase 2 Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer December 1998
NCT01164150 Terminated Phase 2 Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06 March 2010 March 13, 2020
NCT04743999 Terminated Phase 2 Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma February 27, 2020 June 27, 2023
NCT02042885 Terminated Phase 1/Phase 2 A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer January 2014 February 2015
NCT04970368 Terminated Phase 3 Comparison of Nodal Staging in Endometrial Cancer November 5, 2021 June 13, 2023
NCT03099499 Terminated Phase 2 Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer June 8, 2017 September 9, 2020
NCT03077698 Terminated Phase 2 An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer June 14, 2017 July 17, 2020
NCT04514289 Unknown status To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer March 1, 2020 August 30, 2021
NCT04516083 Unknown status Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation December 21, 2019 June 30, 2021
NCT04528940 Unknown status Tumor Grade Determines PD-1/PDL-1 Expression August 25, 2020 September 30, 2021
NCT02433626 Unknown status Phase 1 Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies December 2015 June 2020
NCT00916708 Unknown status N/A Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients September 2008 December 2020
NCT05387460 Unknown status Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial Cancer October 1, 2021 July 1, 2023
NCT00003718 Unknown status Phase 2 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma September 1998
NCT05427058 Unknown status N/A Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management August 1, 2022 April 30, 2023
NCT03804463 Unknown status N/A The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer January 10, 2019 December 31, 2021
NCT01187706 Unknown status A Controlled Study of Quality of Life and it's Related Factors Among Gynecological Cancer Survivors August 2010
NCT02367950 Unknown status N/A Exercise as an Intervention in Endometrial Cancer Survivors January 2015 July 2016
NCT04627740 Unknown status Phase 1/Phase 2 Anti-ALPP CAR-T Cells Immunotherapy for Ovarian and Endometrial Cancer December 1, 2020 December 31, 2023
NCT04651738 Unknown status N/A Cell-free DNA Methylation for Endometrial Cancer December 18, 2020 January 1, 2023
NCT02188550 Unknown status Phase 2 Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer June 2014
NCT04665544 Unknown status N/A Tracers for Endometrial Cancer Sentinel Node Labeling January 1, 2021 January 1, 2024
NCT02178462 Unknown status Biomarkers for Gynecologic Cancer June 2014 March 2018
NCT00800644 Unknown status Pelvic Fractures and Radiation Therapy for Cervical Cancer November 5, 2008 November 30, 2020
NCT04696276 Unknown status N/A Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece January 6, 2020 December 30, 2021
NCT00905658 Unknown status Phase 2 Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer June 2008
NCT03744962 Unknown status MSI in Circulatory DNA of Endometrial Cancer November 10, 2018 December 23, 2020
NCT03827837 Unknown status Phase 2 Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors January 23, 2019 December 2022
NCT03611517 Unknown status N/A Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer August 7, 2018 July 2022
NCT03838055 Unknown status N/A Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease February 2019 December 2023
NCT03595722 Unknown status N/A Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers July 11, 2019 August 28, 2022
NCT03567655 Unknown status Phase 2 Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer July 15, 2018 November 30, 2022
NCT03553589 Unknown status Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma October 1, 2018 June 1, 2021
NCT00173290 Unknown status Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function July 2004 December 2006
NCT03538704 Unknown status N/A Effect of Fertility-sparing Therapy of Early Endometrial Cancer January 1, 2015 December 31, 2020
NCT00373620 Unknown status Phase 2 A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients January 2006
NCT03489473 Unknown status FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment January 1, 2020 December 1, 2021
NCT03459976 Unknown status HE4 is a Beneficial Biomarker in Endometrial Cancer December 1, 2017 April 1, 2019
NCT04010487 Unknown status Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis July 16, 2019 August 1, 2021
NCT03349463 Unknown status Phase 4 Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. November 14, 2018 December 2020
NCT01560026 Unknown status Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma August 2000 December 2012
NCT03322176 Unknown status Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing October 17, 2017 November 1, 2020
NCT04073680 Unknown status Phase 1/Phase 2 A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors September 1, 2020 December 30, 2021
NCT03207126 Unknown status N/A Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? June 13, 2017 January 1, 2022
NCT00601406 Unknown status N/A Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer March 2006
NCT03207061 Unknown status N/A Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? June 13, 2017 January 1, 2022
NCT04157491 Unknown status Phase 1/Phase 2 Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer October 18, 2019 December 31, 2022
NCT00003135 Unknown status Phase 2 Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer November 1997
NCT03000192 Unknown status HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life August 2016 September 2021
NCT02990728 Unknown status Phase 2 Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer March 2016 March 2020
NCT00982631 Unknown status Phase 1 A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer June 2009 August 2012
NCT02762214 Unknown status Phase 3 Role of Uterine Manipulator in Hysterectomy - Ro.Man.HY October 2015 October 2017
NCT04251676 Unknown status Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis January 1, 2010 December 1, 2021
NCT02684318 Unknown status Phase 1/Phase 2 Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors July 2015 October 2019
NCT00166985 Unknown status The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients September 2004 December 2008
NCT01461746 Unknown status Phase 2 Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer October 2011 December 2017
NCT04295109 Unknown status N/A Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function March 2, 2020 July 31, 2020
NCT02667431 Unknown status Cancer of the Uterus and Treatment of Stress Urinary Incontinence January 2016 April 2019
NCT02638402 Unknown status Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers May 2016 August 2017
NCT02580747 Unknown status Phase 1 Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso October 2015 November 2018
NCT01447199 Unknown status The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) September 1994 September 30, 2020
NCT00919919 Unknown status Phase 2 Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen June 2009 November 2010
NCT04444193 Unknown status N/A Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma August 31, 2020 May 31, 2021
NCT02560571 Unknown status Phase 2 Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients October 2015
NCT05290415 Unknown status Host DNA Methylation for Endometrial Cancer Screening March 13, 2022 September 13, 2022
NCT05290922 Unknown status DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening March 12, 2022 March 12, 2023
NCT04489706 Unknown status N/A Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation June 28, 2020 November 2022
NCT01267851 Unknown status Clinical Database and Biobank of Patients With Gynecologic Neoplasms January 1, 2010 December 30, 2020
NCT04890912 Unknown status N/A Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II July 15, 2021 June 1, 2023
NCT01150682 Unknown status Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer July 2010
NCT00003560 Unknown status Phase 2 Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer May 1998
NCT01119573 Unknown status Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer May 2010
NCT01717794 Unknown status N/A Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer October 2012
NCT04958278 Unknown status Pelvic Sentinel Node Detection Using Indocyanine Green Learning Curve July 1, 2021 October 31, 2022
NCT01710085 Unknown status N/A Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients August 2012 February 2014
NCT01100359 Unknown status Phase 2 Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer November 2007
NCT05018195 Unknown status N/A Adipocytokines in Endometrial Cancer September 1, 2021 July 29, 2022
NCT01087268 Unknown status Phase 3 Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer January 2009
NCT05056259 Unknown status Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients January 1, 2022 October 2023
NCT00002465 Unknown status Phase 1/Phase 2 High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma December 1987
NCT01594879 Unknown status Phase 2 Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer January 2012 December 2014
NCT01853865 Unknown status N/A Follow-up of Endometrial Cancer Patients May 2013 April 2019
NCT00758056 Unknown status Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom February 2008
NCT04787159 Unknown status Endometrial Cancer International Database May 2021 March 2022
NCT01779128 Unknown status Early Phase 1 PET-CT vs. Integrated MR-PET Scanning of GYN Cancers March 2013
NCT01761409 Unknown status Epidemiological Analysis on Endometrial Cancer in Guangdong Province of China January 2000
NCT04866394 Unknown status N/A Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS July 3, 2019 April 2024
NCT02042495 Withdrawn Phase 2 Endometrial Cancer Biomarker Changes Following Exposure to Metformin August 2016
NCT03836157 Withdrawn Phase 2 Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer May 31, 2019 May 2022
NCT00003821 Withdrawn Phase 2 Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer January 1998
NCT01290406 Withdrawn Phase 2 BEZ235 Trial in Patients With Advanced Endometrial Carcinoma March 2012 December 2017
NCT00118300 Withdrawn Phase 1 Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer April 2005
NCT02127151 Withdrawn Phase 2 A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer October 1, 2014 May 1, 2017
NCT03115593 Withdrawn N/A Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer July 10, 2018 March 2, 2020
NCT00250016 Withdrawn Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC) August 2003 August 2007
NCT02117817 Withdrawn Phase 1 Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer February 2015 February 25, 2015
NCT01498237 Withdrawn Early Phase 1 Photoacoustic Endoscopy in Endometrial Cancer January 2012 December 2012
NCT04611139 Withdrawn Phase 1 Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers December 31, 2021 June 30, 2024
NCT01097239 Withdrawn Phase 1/Phase 2 Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer November 2009 September 2018
NCT01550380 Withdrawn Phase 2 BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers May 2014 July 2014
Exact Synonym (Disease Ontology)
endometrial Ca
Exact Synonym (Disease Ontology)
endometrial neoplasm
Exact Synonym (Disease Ontology)
malignant endometrial neoplasm
Exact Synonym (Disease Ontology)
malignant neoplasm of endometrium
Exact Synonym (Disease Ontology)
neoplasm of endometrium
Exact Synonym (Disease Ontology)
primary malignant neoplasm of endometrium
Exact Synonym (Disease Ontology)
tumor of Endometrium
Disase is a (Disease Ontology)
DOID:363
Cross Reference ID (Disease Ontology)
EFO:0004230
Cross Reference ID (Disease Ontology)
GARD:11981
Cross Reference ID (Disease Ontology)
ICD10CM:C54.1
Cross Reference ID (Disease Ontology)
KEGG:05213
Cross Reference ID (Disease Ontology)
MESH:D016889
Cross Reference ID (Disease Ontology)
MIM:608089
Cross Reference ID (Disease Ontology)
NCI:C27815
Cross Reference ID (Disease Ontology)
NCI:C3012
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:123844007
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:188192002
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0007103
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0014170